Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zevalin in untreated follicular lymphoma
NCT01493479Phase 2Completed
- Sponsor
- The Christie
- Start
- Jun 2007
- Primary completion
- Jan 2011
- Modality
- Recombinant Proteins and Enzymes, Monoclonal Antibodies
- Countries
- 2
01
Overview
A Phase 2 trial of ibritumomab tiuxetan in follicular lymphoma (FL), sponsored by The Christie. Started Jun 2007; status: completed.
02
Drugs
ibritumomab tiuxetan
03
Conditions
follicular lymphoma (FL)
Beyond the preview
Go deeper on NCT01493479.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01493479.